These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 9567769)

  • 1. In vitro transcorneal permeation of ketorolac from oil based ocular drops and ophthalmic ointment.
    Malhotra M; Majumdar DK
    Indian J Exp Biol; 1997 Dec; 35(12):1324-30. PubMed ID: 9567769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro transcorneal permeation of ketorolac tromethamine from buffered and unbuffered aqueous ocular drops.
    Malhotra M; Majumdar DK
    Indian J Exp Biol; 1997 Sep; 35(9):941-7. PubMed ID: 9475074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of preservative, antioxidant and viscolizing agents on in vitro transcorneal permeation of ketorolac tromethamine.
    Malhotra M; Majumdar DK
    Indian J Exp Biol; 2002 May; 40(5):555-9. PubMed ID: 12622201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro corneal permeation of diclofenac from oil drops.
    Ahuja M; Sharma SK; Majumdar DK
    Yakugaku Zasshi; 2007 Oct; 127(10):1739-45. PubMed ID: 17917432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of concentration, pH, and preservative on in vitro transcorneal permeation of ibuprofen and flurbiprofen from non-buffered aqueous drops.
    Gupta M; Majumdar DK
    Indian J Exp Biol; 1997 Aug; 35(8):844-9. PubMed ID: 9475059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro permeation characteristics of moxifloxacin from oil drops through excised goat, sheep, buffalo and rabbit corneas.
    Pawar PK; Majumdar DK
    Pharmazie; 2007 Nov; 62(11):853-7. PubMed ID: 18065102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of benzalkonium chloride/EDTA on the ocular bioavailability of ketorolac tromethamine following ocular instillation to normal and de-epithelialized corneas of rabbits.
    Madhu C; Rix PJ; Shackleton MJ; Nguyen TG; Tang-Liu DD
    J Pharm Sci; 1996 Apr; 85(4):415-8. PubMed ID: 8901080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aceclofenac oil drops: characterization and evaluation against ocular inflammation.
    Katara R; Sachdeva S; Majumdar DK
    Pharm Dev Technol; 2018 Mar; 23(3):240-246. PubMed ID: 28565934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of formulation factors on in vitro transcorneal permeation of gatifloxacin from aqueous drops.
    Rathore MS; Majumdar DK
    AAPS PharmSciTech; 2006 Jul; 7(3):57. PubMed ID: 17025238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of in vitro transcorneal approach of aceclofenac eye drops through excised goat, sheep, and buffalo corneas.
    Dave V; Paliwal S; Yadav S; Sharma S
    ScientificWorldJournal; 2015; 2015():432376. PubMed ID: 25654129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraocular penetration of periocular ketorolac and efficacy in experimental uveitis.
    Rabiah PK; Fiscella RG; Tessler HH
    Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):613-8. PubMed ID: 8595961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailability and anticataract effects of a topical ocular drug delivery system containing disulfiram and hydroxypropyl-beta-cyclodextrin on selenite-treated rats.
    Wang S; Li D; Ito Y; Nabekura T; Wang S; Zhang J; Wu C
    Curr Eye Res; 2004 Jul; 29(1):51-8. PubMed ID: 15370367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of formulation factors on in vitro permeation of moxifloxacin from aqueous drops through excised goat, sheep, and buffalo corneas.
    Pawar PK; Majumdar DK
    AAPS PharmSciTech; 2006 Feb; 7(1):E13. PubMed ID: 16584143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nasal formulations of ketorolac tromethamine: technological evaluation--bioavailability and tolerability in rabbits.
    Santus G; Rivolta R; Bottoni G; Testa B; Canali S; Peano S
    Farmaco; 1993 Dec; 48(12):1709-23. PubMed ID: 8135994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antinociceptive and anti-inflammatory effects of five depot formulations of ketorolac propyl ester in rats.
    Wang LK; Wang PJ; Hou CH; Chu CC; Tzeng JI; Shieh JP; Wang JJ
    Acta Anaesthesiol Taiwan; 2005 Jun; 43(2):85-92. PubMed ID: 16060403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety profile of ketorolac 0.5% ophthalmic solution in the prevention of surgically induced miosis during cataract surgery.
    Stewart R; Grosserode R; Cheetham JK; Rosenthal A
    Clin Ther; 1999 Apr; 21(4):723-32. PubMed ID: 10363737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonsteroidal eye drops for ocular allergy.
    Schwab IR
    West J Med; 1994 Dec; 161(6):594-5. PubMed ID: 7856163
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of topical ketorolac and diclofenac on normal corneal sensation.
    Sun R; Gimbel HV
    J Refract Surg; 1997; 13(2):158-61. PubMed ID: 9109072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo ocular availability of ketorolac following ocular instillations of aqueous, oil, and ointment formulations to normal corneas of rabbits: a technical note.
    Malhotra M; Majumdar DK
    AAPS PharmSciTech; 2005 Oct; 6(3):E523-6. PubMed ID: 16354013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of topical nonsteroidal anti-inflammatory drops and no pressure patching in the treatment of corneal abrasions. Corneal Abrasion Patching Study Group.
    Kaiser PK; Pineda R
    Ophthalmology; 1997 Aug; 104(8):1353-9. PubMed ID: 9261326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.